EQUITY RESEARCH MEMO

Bioapp Solutions

Generated 5/10/2026

Executive Summary

Conviction (model self-assessment)45/100

Bioapp Solutions is a London-based digital health and AI/ML company founded in 2018. Despite its recent founding, the team brings over 90 years of combined experience in the CRO, pharma, and clinical markets. The company focuses on delivering innovative analytical solutions and is committed to nurturing the next generation of analytical scientists. Bioapp aims to address the growing demand for efficiency and accuracy in drug development and clinical trials by leveraging AI and machine learning. Its niche in analytical services positions it to support clients with feasibility studies and method development, though specific products or platforms remain undisclosed. The company is privately held with no disclosed funding rounds, suggesting an early-stage or bootstrapped status.

Upcoming Catalysts (preview)

  • TBDStrategic Partnership with a Pharma or CRO30% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)